Doxycycline hyclate controlled release - POLYPID

Drug Profile

Doxycycline hyclate controlled release - POLYPID

Alternative Names: D-PLEX; Doxycycline/polymer-lipid encapsulation matrix

Latest Information Update: 21 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator POLYPID
  • Class Antibacterials; Antimalarials; Small molecules; Tetracyclines
  • Mechanism of Action Protein 30S ribosomal subunit inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Postoperative infections

Most Recent Events

  • 16 Aug 2017 POLYPID completes enrolment in its phase I/II trial for Post-operative infections in Israel (NCT02731573)
  • 31 Mar 2017 Chemical structure information added
  • 08 Mar 2017 Doxycycline hyclate controlled release - POLYPID receives Qualified Infectious Disease Product status for Postoperative infections in USA
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top